Phaxiam to delist ADS from Nasdaq in March

Phaxiam Therapeutics says it has notified the Nasdaq Stock Market of its intention to voluntarily delist its American Depositary Shares representing its ordinary shares, which should be effective...

Related Keywords

Eric Soyer ,Erytech Pharma , ,Phaxiam Therapeutics ,Nasdaq Stock Market ,American Depositary Shares ,Euronext Paris ,Nasdaq Global Select Market ,Nasdaq Capital Market ,Markets ,